Skip to Content

3,922 Results Found

  • Review
  • Open Access
275 Citations
20,573 Views
24 Pages

7 November 2016

The Bromodomain and Extra-Terminal Domain (BET) family of proteins is characterized by the presence of two tandem bromodomains and an extra-terminal domain. The mammalian BET family of proteins comprises BRD2, BRD3, BRD4, and BRDT, which are encoded...

  • Review
  • Open Access
3 Citations
3,468 Views
16 Pages

A Minireview on BET Inhibitors: Beyond Bromodomain Targeting

  • Mikhail S. Iudin,
  • Yuri M. Khodarovich,
  • Anna M. Varizhuk,
  • Vladimir B. Tsvetkov and
  • Vyacheslav V. Severov

Bromodomain and extra-terminal domain (BET) proteins are epigenetic readers that recognize the histone acetylation code and play a critical role in regulating gene transcription. Dysregulation of BET proteins is associated with a number of pathologie...

  • Review
  • Open Access
14 Citations
4,887 Views
25 Pages

Relevance of BET Family Proteins in SARS-CoV-2 Infection

  • Nieves Lara-Ureña and
  • Mario García-Domínguez

30 July 2021

The recent pandemic we are experiencing caused by the coronavirus disease 2019 (COVID-19) has put the world’s population on the rack, with more than 191 million cases and more than 4.1 million deaths confirmed to date. This disease is caused by a new...

  • Article
  • Open Access
9 Citations
3,241 Views
15 Pages

Targeting BET Proteins Decreases Hyaluronidase-1 in Pancreatic Cancer

  • Krishan Kumar,
  • Deepak Kanojia,
  • David J. Bentrem,
  • Rosa F. Hwang,
  • Jonathan P. Butchar,
  • Susheela Tridandapani and
  • Hidayatullah G. Munshi

27 May 2023

Background: Pancreatic ductal adenocarcinoma (PDAC) is characterized by the presence of dense stroma that is enriched in hyaluronan (HA), with increased HA levels associated with more aggressive disease. Increased levels of the HA-degrading enzymes h...

  • Review
  • Open Access
12 Citations
5,408 Views
11 Pages

Heart failure is a complex disease process with underlying aberrations in neurohormonal systems that promote dysregulated cellular signaling and gene transcription. Over the past 10 years, the advent of small-molecule inhibitors that target transcrip...

  • Review
  • Open Access
62 Citations
10,669 Views
29 Pages

BET Proteins as Attractive Targets for Cancer Therapeutics

  • Joanna Sarnik,
  • Tomasz Popławski and
  • Paulina Tokarz

14 October 2021

Transcriptional dysregulation is a hallmark of cancer and can be an essential driver of cancer initiation and progression. Loss of transcriptional control can cause cancer cells to become dependent on certain regulators of gene expression. Bromodomai...

  • Review
  • Open Access
76 Citations
15,844 Views
38 Pages

BET Bromodomain Inhibitors: Novel Design Strategies and Therapeutic Applications

  • Kenneth K. W. To,
  • Enming Xing,
  • Ross C. Larue and
  • Pui-Kai Li

29 March 2023

The mammalian bromodomain and extra-terminal domain (BET) family of proteins consists of four conserved members (Brd2, Brd3, Brd4, and Brdt) that regulate numerous cancer-related and immunity-associated genes. They are epigenetic readers of histone a...

  • Article
  • Open Access
5 Citations
3,860 Views
16 Pages

BET Proteins Regulate Expression of Osr1 in Early Kidney Development

  • Janina Schreiber,
  • Nastassia Liaukouskaya,
  • Lars Fuhrmann,
  • Alexander-Thomas Hauser,
  • Manfred Jung,
  • Tobias B. Huber and
  • Nicola Wanner

10 December 2021

In utero renal development is subject to maternal metabolic and environmental influences affecting long-term renal function and the risk of developing chronic kidney failure and cardiovascular disease. Epigenetic processes have been implicated in the...

  • Review
  • Open Access
10 Citations
2,931 Views
15 Pages

11 August 2023

The bromodomain and extra-terminal domain (BET) family inhibitors are small molecules that target the dysregulated epigenetic readers, BRD2, BRD3, BRD4 and BRDT, at various transcription-related sites, including super-enhancers. BET inhibitors are cu...

  • Review
  • Open Access
27 Citations
6,503 Views
12 Pages

19 July 2023

The term allergy was coined in 1906 by the Austrian scientist and pediatrician Clemens Freiherr von Pirquet. In 1976, Dietrich Kraft became the head of the Allergy and Immunology Research Group at the Department of General and Experimental Pathology...

  • Article
  • Open Access
52 Citations
5,946 Views
16 Pages

Quercetin Enhances the Anti-Tumor Effects of BET Inhibitors by Suppressing hnRNPA1

  • Thao N.D. Pham,
  • Sophie Stempel,
  • Mario A. Shields,
  • Christina Spaulding,
  • Krishan Kumar,
  • David J. Bentrem,
  • Maria Matsangou and
  • Hidayatullah G. Munshi

2 September 2019

Bromodomain and extraterminal domain (BET) proteins, which are important epigenetic readers, are often dysregulated in cancer. While a number of BET inhibitors are currently in early phase clinical trials, BET inhibitors show limited single-agent act...

  • Article
  • Open Access
29 Citations
4,273 Views
17 Pages

BET-Inhibitor I-BET762 and PARP-Inhibitor Talazoparib Synergy in Small Cell Lung Cancer Cells

  • Francesco Paolo Fiorentino,
  • Irene Marchesi,
  • Christoph Schröder,
  • Ronny Schmidt,
  • Jun Yokota and
  • Luigi Bagella

16 December 2020

Small cell lung cancer (SCLC) is an aggressive type of lung cancer with high mortality that is caused by frequent relapses and acquired resistance. Despite that several target-based approaches with potential therapeutic impact on SCLC have been ident...

  • Abstract
  • Open Access
827 Views
2 Pages

Anticancer Effects of the Potential BET Inhibitor CBL0137 on Breast Cancer Cells

  • Valeriia Popova,
  • Varvara Maksimova,
  • Evgeniya Lylova,
  • Anzhelika Bukina,
  • Marianna Yakubovskaya and
  • Kirill Kirsanov

Breast cancer (BC) is a complex disease driven by a combination of genetic mutations and epigenetic modifications. In particular, the overexpression of BET family proteins (BETs) has emerged as a key epigenetic aberration contributing to BC pathogene...

  • Review
  • Open Access
7 Citations
5,363 Views
21 Pages

Targeting Epigenetic Regulators with HDAC and BET Inhibitors to Modulate Muscle Wasting

  • Lorenzo Nevi,
  • Noora Pöllänen,
  • Fabio Penna and
  • Giuseppina Caretti

16 November 2023

Epigenetic changes contribute to the profound alteration in the transcriptional program associated with the onset and progression of muscle wasting in several pathological conditions. Although HDACs and their inhibitors have been extensively studied...

  • Review
  • Open Access
12 Citations
5,427 Views
23 Pages

Foamy Viruses, Bet, and APOBEC3 Restriction

  • Ananda Ayyappan Jaguva Vasudevan,
  • Daniel Becker,
  • Tom Luedde,
  • Holger Gohlke and
  • Carsten Münk

18 March 2021

Non-human primates (NHP) are an important source of viruses that can spillover to humans and, after adaptation, spread through the host population. Whereas HIV-1 and HTLV-1 emerged as retroviral pathogens in humans, a unique class of retroviruses cal...

  • Article
  • Open Access
17 Citations
4,176 Views
19 Pages

The BET Inhibitor OTX015 Exhibits In Vitro and In Vivo Antitumor Activity in Pediatric Ependymoma Stem Cell Models

  • Tiziana Servidei,
  • Daniela Meco,
  • Maurizio Martini,
  • Alessandra Battaglia,
  • Alessia Granitto,
  • Alexia Buzzonetti,
  • Gabriele Babini,
  • Luca Massimi,
  • Gianpiero Tamburrini and
  • Riccardo Riccardi
  • + 2 authors

13 February 2021

Childhood ependymomas are heterogenous chemoresistant neoplasms arising from aberrant stem-like cells. Epigenome deregulation plays a pivotal role in ependymoma pathogenesis, suggesting that epigenetic modifiers hold therapeutic promise against this...

  • Review
  • Open Access
147 Citations
14,005 Views
9 Pages

BET Family Protein BRD4: An Emerging Actor in NFκB Signaling in Inflammation and Cancer

  • Azadeh Hajmirza,
  • Anouk Emadali,
  • Arnaud Gauthier,
  • Olivier Casasnovas,
  • Rémy Gressin and
  • Mary B. Callanan

NFκB (Nuclear Factor-κ-light-chain-enhancer of activated B cells) signaling elicits global transcriptional changes by activating cognate promoters and through genome-wide remodeling of cognate regulatory elements called “super enhancers”. BET (Bromod...

  • Article
  • Open Access
1,489 Views
10 Pages

The Development and Evaluation of a Novel Highly Selective PET Radiotracer for Targeting BET BD1

  • Yanli Wang,
  • Yongle Wang,
  • Yulong Xu,
  • Leyi Kang,
  • Darcy Tocci and
  • Changning Wang

27 September 2024

Background/Objectives: Small molecules that interfere with the interaction between acetylated protein tails and the tandem bromodomains of BET (bromodomain and extra-terminal) family proteins are pivotal in modulating immune/inflammatory and neoplast...

  • Article
  • Open Access
6 Citations
3,723 Views
11 Pages

T-Bet Deficiency Attenuates Bile Duct Injury in Experimental Biliary Atresia

  • Sujit K. Mohanty,
  • Bryan Donnelly,
  • Haley Temple,
  • Alexander Bondoc,
  • Monica McNeal and
  • Greg Tiao

8 December 2021

Biliary atresia (BA) is an obstructive neonatal cholangiopathy leading to liver cirrhosis and end stage liver disease. A Kasai portoenterostomy may restore biliary drainage, but most patients ultimately require liver transplantation for survival. At...

  • Article
  • Open Access
5 Citations
2,950 Views
19 Pages

Modulation of Virulence-Associated Traits in Aspergillus fumigatus by BET Inhibitor JQ1

  • Anastasia Orekhova,
  • Marta De Angelis,
  • Andrea Cacciotti,
  • Massimo Reverberi,
  • Dante Rotili,
  • Alessandra Giorgi,
  • Virginia Protto,
  • Graziana Bonincontro,
  • Francesco Fiorentino and
  • Giovanna Simonetti
  • + 3 authors

Aspergillus fumigatus is a disease-causing, opportunistic fungus that can establish infection due to its capacity to respond to a wide range of environmental conditions. Secreted proteins and metabolites, which play a critical role in fungal–ho...

  • Article
  • Open Access
7 Citations
3,047 Views
25 Pages

Evaluation of the Synergistic Potential of Simultaneous Pan- or Isoform-Specific BET and SYK Inhibition in B-Cell Lymphoma: An In Vitro Approach

  • Sina Sender,
  • Ahmad Wael Sultan,
  • Daniel Palmer,
  • Dirk Koczan,
  • Anett Sekora,
  • Julia Beck,
  • Ekkehard Schuetz,
  • Leila Taher,
  • Bertram Brenig and
  • Hugo Murua Escobar
  • + 2 authors

27 September 2022

Background: Both bromodomain and extra-terminal domain (BET) proteins and spleen tyrosine kinase (SYK) represent promising targets in diffuse large B-cell (DLBCL) and Burkitt’s lymphoma (BL). We evaluated the anti-lymphoma activity of the isofo...

  • Review
  • Open Access
65 Citations
7,891 Views
28 Pages

5 March 2019

Histone DeACetylases (HDACs) are enzymes that remove acetyl groups from histones and other proteins, regulating the expression of target genes. Pharmacological inhibition of these enzymes re-shapes chromatin acetylation status, confusing boundaries b...

  • Article
  • Open Access
12 Citations
7,014 Views
16 Pages

Effect of Cytomegalovirus (CMV) and Ageing on T-Bet and Eomes Expression on T-Cell Subsets

  • Fakhri Hassouneh,
  • Nelson Lopez-Sejas,
  • Carmen Campos,
  • Beatriz Sanchez-Correa,
  • Raquel Tarazona,
  • Alejandra Pera and
  • Rafael Solana

The differential impact of ageing and cytomegalovirus (CMV) latent infection on human T-cell subsets remains to some extent controversial. The purpose of this study was to analyse the expression of the transcription factors T-bet and Eomes and CD57 o...

  • Article
  • Open Access
14 Citations
4,057 Views
20 Pages

Type IV Collagen and SOX9 Are Molecular Targets of BET Inhibition in Experimental Glomerulosclerosis

  • José Luis Morgado-Pascual,
  • Beatriz Suarez-Alvarez,
  • Vanessa Marchant,
  • Pamela Basantes,
  • Pierre-Louis Tharaux,
  • Alberto Ortiz,
  • Carlos Lopez-Larrea,
  • Marta Ruiz-Ortega and
  • Sandra Rayego-Mateos

28 December 2022

Progressive glomerulonephritis (GN) is characterized by an excessive accumulation of extracellular (ECM) proteins, mainly type IV collagen (COLIV), in the glomerulus leading to glomerulosclerosis. The current therapeutic approach to GN is suboptimal....

  • Article
  • Open Access
24 Citations
6,132 Views
15 Pages

The BET Inhibitor JQ1 Augments the Antitumor Efficacy of Gemcitabine in Preclinical Models of Pancreatic Cancer

  • Aubrey L. Miller,
  • Patrick L. Garcia,
  • Samuel C. Fehling,
  • Tracy L. Gamblin,
  • Rebecca B. Vance,
  • Leona N. Council,
  • Dongquan Chen,
  • Eddy S. Yang,
  • Robert C. A. M. van Waardenburg and
  • Karina J. Yoon

11 July 2021

Gemcitabine is used to treat pancreatic cancer (PC), but is not curative. We sought to determine whether gemcitabine + a BET bromodomain inhibitor was superior to gemcitabine, and identify proteins that may contribute to the efficacy of this combinat...

  • Article
  • Open Access
12 Citations
3,345 Views
14 Pages

Inhibition of BET Proteins Regulates Fcγ Receptor Function and Reduces Inflammation in Rheumatoid Arthritis

  • Divya Shankar,
  • Giovanna Merchand-Reyes,
  • Nathaniel J. Buteyn,
  • Ramasamy Santhanam,
  • Huiqing Fang,
  • Krishan Kumar,
  • Xiaokui Mo,
  • Latha P. Ganesan,
  • Wael Jarjour and
  • Susheela Tridandapani
  • + 1 author

Overactivation of immune responses is a hallmark of autoimmune disease pathogenesis. This includes the heightened production of inflammatory cytokines such as Tumor Necrosis Factor α (TNFα), and the secretion of autoantibodies such as iso...

  • Communication
  • Open Access
40 Citations
4,307 Views
13 Pages

26 September 2019

Type 1 diabetes (T1D) results from the progressive loss of pancreatic beta cells as a result of autoimmune destruction. We recently reported that during the natural history of T1D in humans and the female nonobese diabetic (NOD) mouse model, beta cel...

  • Review
  • Open Access
6 Citations
4,385 Views
26 Pages

BET proteins are a family of multifunctional epigenetic readers, mainly involved in transcriptional regulation through chromatin modelling. Transcriptome handling ability of BET proteins suggests a key role in the modulation of cell plasticity, both...

  • Article
  • Open Access
9 Citations
3,856 Views
19 Pages

The correct phagocytic activity of microglia is a prerequisite for maintaining homeostasis in the brain. In the analysis of mechanisms regulating microglial phagocytosis, we focused on the bromodomain and extraterminal domain (BET) proteins: Brd2, Br...

  • Article
  • Open Access
7 Citations
3,654 Views
19 Pages

BET Protein Inhibitor JQ1 Ameliorates Experimental Peritoneal Damage by Inhibition of Inflammation and Oxidative Stress

  • Vanessa Marchant,
  • Flavia Trionfetti,
  • Lucia Tejedor-Santamaria,
  • Sandra Rayego-Mateos,
  • Dante Rotili,
  • Giulio Bontempi,
  • Alessandro Domenici,
  • Paolo Menè,
  • Antonello Mai and
  • Marta Ruiz-Ortega
  • + 4 authors

29 November 2023

Peritoneal dialysis (PD) is a current replacement therapy for end-stage kidney diseases (ESKDs). However, long-term exposure to PD fluids may lead to damage of the peritoneal membrane (PM) through mechanisms involving the activation of the inflammato...

  • Article
  • Open Access
2,143 Views
19 Pages

BET Protein Inhibition Relieves MDSC-Mediated Immune Suppression in Chronic Lymphocytic Leukemia

  • Erin M. Drengler,
  • Audrey L. Smith,
  • Sydney A. Skupa,
  • Elizabeth Schmitz,
  • Eslam Mohamed and
  • Dalia El-Gamal

24 May 2025

Background: Myeloid-derived suppressor cells (MDSCs) contribute to immune suppression observed in chronic lymphocytic leukemia (CLL). MDSCs are immature myeloid cells that are hijacked during development and further reprogrammed by the tumor microenv...

  • Article
  • Open Access
5 Citations
4,039 Views
16 Pages

A BET Protein Inhibitor Targeting Mononuclear Myeloid Cells Affects Specific Inflammatory Mediators and Pathways in Crohn’s Disease

  • Ahmed M. I. Elfiky,
  • Ishtu L. Hageman,
  • Marte A. J. Becker,
  • Jan Verhoeff,
  • Andrew Y. F. Li Yim,
  • Vincent W. Joustra,
  • Lieven Mulders,
  • Ivan Fung,
  • Inmaculada Rioja and
  • Wouter J. de Jonge
  • + 8 authors

12 September 2022

Background: Myeloid cells are critical determinants of the sustained inflammation in Crohn’s Disease (CD). Targeting such cells may be an effective therapeutic approach for refractory CD patients. Bromodomain and extra-terminal domain protein i...

  • Article
  • Open Access
1 Citations
1,426 Views
38 Pages

Volatility Spillovers Between the U.S. and Romanian Markets: The BET–SFT-500 Dynamic Under Political Uncertainty

  • Kamer-Ainur Aivaz,
  • Lavinia Mastac,
  • Dorin Jula,
  • Diane Paula Corina Vancea,
  • Cristina Duhnea and
  • Elena Condrea

13 August 2025

This paper analyzes the volatility relationship between the Romanian BET index and the U.S. SFT-500 index during the period 2019–2024, with a particular focus on the impact of political and geopolitical shocks. The study investigates whether fi...

  • Article
  • Open Access
34 Citations
6,185 Views
16 Pages

Inhibition of Bromodomain and Extraterminal Domain (BET) Proteins by JQ1 Unravels a Novel Epigenetic Modulation to Control Lipid Homeostasis

  • Claudia Tonini,
  • Mayra Colardo,
  • Barbara Colella,
  • Sabrina Di Bartolomeo,
  • Francesco Berardinelli,
  • Giuseppina Caretti,
  • Valentina Pallottini and
  • Marco Segatto

14 February 2020

The homeostatic control of lipid metabolism is essential for many fundamental physiological processes. A deep understanding of its regulatory mechanisms is pivotal to unravel prospective physiopathological factors and to identify novel molecular targ...

  • Article
  • Open Access
3 Citations
3,698 Views
21 Pages

BET and CDK Inhibition Reveal Differences in the Proliferation Control of Sympathetic Ganglion Neuroblasts and Adrenal Chromaffin Cells

  • Jessica Sriha,
  • Caroline Louis-Brennetot,
  • Cécile Pierre-Eugène,
  • Sylvain Baulande,
  • Virginie Raynal,
  • Amira Kramdi,
  • Igor Adameyko,
  • Uwe Ernsberger,
  • Thomas Deller and
  • Hermann Rohrer
  • + 2 authors

1 June 2022

Neuroblastoma arising from the adrenal differ from ganglionic neuroblastoma both genetically and clinically, with adrenal tumors being associated with a more severe prognosis. The different tumor properties may be linked to specific tumor founder cel...

  • Feature Paper
  • Article
  • Open Access
7 Citations
10,760 Views
14 Pages

Hedging on Betting Markets

  • Gustav Axén and
  • Dominic Cortis

25 August 2020

The possibility to use hedging strategies is an often neglected aspect in the literature on prediction/betting markets, as most papers assume that bettors will bet according to their beliefs about the probability of the outcome of the event, as oppos...

  • Article
  • Open Access
7 Citations
5,119 Views
17 Pages

Overexpression of T-bet, GATA-3 and TGF-ß Induces IFN-γ, IL-4/13A, and IL-17A Expression in Atlantic Salmon

  • Tiril H. Slettjord,
  • Hege J. Sekkenes,
  • Heng Chi,
  • Jarl Bøgwald,
  • Trilochan Swain,
  • Roy A. Dalmo and
  • Jaya Kumari Swain

20 April 2020

The overexpression of GATA-3, T-bet and TGF-ß may theoretically induce IL-4/A, IFN-γ and IL-17A expression, respectively. Whether this also applies to fish is not yet known. The plasmid vectors encoding reporter gene (RFP)-tagged T-bet, G...

  • Article
  • Open Access
11 Citations
3,499 Views
18 Pages

Efficacy of Oncolytic Herpes Simplex Virus T-VEC Combined with BET Inhibitors as an Innovative Therapy Approach for NUT Carcinoma

  • Paul V. Ohnesorge,
  • Susanne Berchtold,
  • Julia Beil,
  • Simone A. Haas,
  • Irina Smirnow,
  • Andrea Schenk,
  • Christopher A. French,
  • Nhi M. Luong,
  • Yeying Huang and
  • Ulrich M. Lauer
  • + 2 authors

2 June 2022

NUT carcinoma (NC) is an extremely aggressive tumor and current treatment regimens offer patients a median survival of six months only. This article reports on the first in vitro studies using immunovirotherapy as a promising therapy option for NC an...

  • Article
  • Open Access
12 Citations
4,382 Views
16 Pages

Binding to Iron Quercetin Complexes Increases the Antioxidant Capacity of the Major Birch Pollen Allergen Bet v 1 and Reduces Its Allergenicity

  • Andreas Regner,
  • Nathalie Szepannek,
  • Markus Wiederstein,
  • Aila Fakhimahmadi,
  • Luis F. Paciosis,
  • Bart R. Blokhuis,
  • Frank A. Redegeld,
  • Gerlinde Hofstetter,
  • Zdenek Dvorak and
  • Franziska Roth-Walter
  • + 2 authors

26 December 2022

Bet v 1 is the major allergen in birch pollen to which up to 95% of patients sensitized to birch respond. As a member of the pathogenesis-related PR 10 family, its natural function is implicated in plant defense, with a member of the PR10 family bein...

  • Article
  • Open Access
1,053 Views
14 Pages

BET Inhibitor JQ1 Attenuates Atrial Fibrillation Through Modulation of Fibrosis, Calcium Homeostasis, and Mitochondrial Function in a Murine Model

  • Zonghu Song,
  • Nobuyuki Murakoshi,
  • Dongzhu Xu,
  • Binyang Xi,
  • Yoshiko Murakata,
  • Kazuhiro Aonuma,
  • Kazuko Tajiri and
  • Tomoko Ishizu

24 October 2025

Bromodomain and extraterminal domain (BET) proteins act as epigenetic regulators of gene transcription. BET inhibitors have shown therapeutic potential in various models of heart failure; however, their efficacy in atrial fibrillation (AF) remains in...

  • Article
  • Open Access
4 Citations
2,416 Views
19 Pages

Sensitization Potential of the Major Soybean Allergen Gly m 4 and Its Cross-Reactivity with the Birch Pollen Allergen Bet v 1

  • Ekaterina I. Finkina,
  • Yulia D. Danilova,
  • Daria N. Melnikova,
  • Tatiana V. Ovchinnikova and
  • Ivan V. Bogdanov

The birch pollen allergen Bet v 1 is believed to be the main sensitizer among PR-10 allergens. Recent data have shown that some other PR-10 allergens also display sensitization activities, and Bet v 1-based immunotherapy is not effective for blocking...

  • Article
  • Open Access
4 Citations
3,398 Views
19 Pages

BET Protein Inhibitor JQ1 Modulates Mitochondrial Dysfunction and Oxidative Stress Induced by Chronic Kidney Disease

  • Sandra Rayego-Mateos,
  • Pamela Basantes,
  • José Luis Morgado-Pascual,
  • Beatriz Brazal Prieto,
  • Beatriz Suarez-Alvarez,
  • Alberto Ortiz,
  • Carlos Lopez-Larrea and
  • Marta Ruiz-Ortega

Among the mechanisms involved in the progression of kidney disease, mitochondrial dysfunction has special relevance. Epigenetic drugs such as inhibitors of extra-terminal domain proteins (iBET) have shown beneficial effects in experimental kidney dis...

  • Article
  • Open Access
1 Citations
4,720 Views
15 Pages

31 August 2023

Feline leukemia virus (FeLV) is a cosmopolitan gammaretrovirus that causes lifelong infections and fatal diseases, including leukemias, lymphomas, immunodeficiencies, and anemias, in domestic and wild felids. There is currently no definitive treatmen...

  • Article
  • Open Access
22 Citations
4,443 Views
15 Pages

26 March 2020

Currently, proteasome inhibitors bortezomib, carfilzomib, and ixazomib are successfully used in clinics to treat multiple myeloma. However, these agents show limited efficacy against solid tumors. Identification of drugs that can potentiate the actio...

  • Article
  • Open Access
5 Citations
3,399 Views
18 Pages

RAS Mediates BET Inhibitor-Endued Repression of Lymphoma Migration and Prognosticates a Novel Proteomics-Based Subgroup of DLBCL through Its Negative Regulator IQGAP3

  • Chih-Cheng Chen,
  • Chia-Chen Hsu,
  • Sung-Lin Chen,
  • Po-Han Lin,
  • Ju-Pei Chen,
  • Yi-Ru Pan,
  • Cih-En Huang,
  • Ying-Ju Chen,
  • Yi-Yang Chen and
  • Muh-Hwa Yang
  • + 1 author

7 October 2021

Phenotypic heterogeneity and molecular diversity make diffuse large B-cell lymphoma (DLBCL) a challenging disease. We recently illustrated that amoeboid movement plays an indispensable role in DLBCL dissemination and inadvertently identified that the...

  • Article
  • Open Access
2 Citations
4,382 Views
22 Pages

Apabetalone, a Clinical-Stage, Selective BET Inhibitor, Opposes DUX4 Target Gene Expression in Primary Human FSHD Muscle Cells

  • Christopher D. Sarsons,
  • Dean Gilham,
  • Laura M. Tsujikawa,
  • Sylwia Wasiak,
  • Li Fu,
  • Brooke D. Rakai,
  • Stephanie C. Stotz,
  • Agostina Carestia,
  • Michael Sweeney and
  • Ewelina Kulikowski

30 September 2023

Facioscapulohumeral dystrophy (FSHD) is a muscle disease caused by inappropriate expression of the double homeobox 4 (DUX4) gene in skeletal muscle, and its downstream activation of pro-apoptotic transcriptional programs. Inhibitors of DUX4 expressio...

  • Article
  • Open Access
1,252 Views
16 Pages

Investigation of Halloumi Cheese Adulteration Due to the Addition of Milk Powder Using BET and FTIR Measurements

  • Maria Tarapoulouzi,
  • Małgorzata Ruggiero-Mikołajczyk,
  • Ioannis Pashalidis and
  • Charis R. Theocharis

8 September 2025

Halloumi cheese, a traditional Cypriot dairy product with Protected Designation of Origin (PDO) status, is renowned for its unique texture and high melting point. PDO certification is crucial for Halloumi cheese as it ensures the product’s auth...

  • Article
  • Open Access
17 Citations
9,451 Views
31 Pages

Systems Biology Approach Identifies Prognostic Signatures of Poor Overall Survival and Guides the Prioritization of Novel BET-CHK1 Combination Therapy for Osteosarcoma

  • Pankita H. Pandya,
  • Lijun Cheng,
  • M. Reza Saadatzadeh,
  • Khadijeh Bijangi-Vishehsaraei,
  • Shan Tang,
  • Anthony L. Sinn,
  • Melissa A. Trowbridge,
  • Kathryn L. Coy,
  • Barbara J. Bailey and
  • Karen E. Pollok
  • + 18 authors

26 August 2020

Osteosarcoma (OS) patients exhibit poor overall survival, partly due to copy number variations (CNVs) resulting in dysregulated gene expression and therapeutic resistance. To identify actionable prognostic signatures of poor overall survival, we empl...

  • Article
  • Open Access
3 Citations
3,800 Views
17 Pages

Insights into the Mechanism of Curaxin CBL0137 Epigenetic Activity: The Induction of DNA Demethylation and the Suppression of BET Family Proteins

  • Varvara Maksimova,
  • Valeriia Popova,
  • Anzhelika Prus,
  • Evgeniya Lylova,
  • Olga Usalka,
  • Guzel Sagitova,
  • Ekaterina Zhidkova,
  • Julia Makus,
  • Ekaterina Trapeznikova and
  • Kirill Kirsanov
  • + 2 authors

17 August 2023

The development of malignant tumors is caused by a complex combination of genetic mutations and epigenetic alterations, the latter of which are induced by either external environmental factors or signaling disruption following genetic mutations. Some...

of 79